SPECTRUM PHARMACEUTICALS INC's ticker is SPPI and the CUSIP is 84763A108. A total of 121 filers reported holding SPECTRUM PHARMACEUTICALS INC in Q2 2013. The put-call ratio across all filers is 1.69 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $112,992 | +10.7% | 117,700 | -13.5% | 0.00% | – |
Q1 2023 | $102,075 | -44.0% | 136,100 | -72.5% | 0.00% | – |
Q4 2022 | $182,404 | +68.9% | 494,992 | +95.9% | 0.00% | – |
Q3 2022 | $108,000 | -84.1% | 252,700 | -71.0% | 0.00% | – |
Q2 2022 | $679,000 | +309.0% | 870,828 | +573.9% | 0.00% | – |
Q1 2022 | $166,000 | -78.8% | 129,213 | -79.0% | 0.00% | – |
Q4 2021 | $782,000 | +34.4% | 616,019 | +130.4% | 0.00% | – |
Q3 2021 | $582,000 | -57.0% | 267,335 | -26.0% | 0.00% | – |
Q2 2021 | $1,355,000 | +75.3% | 361,174 | +52.4% | 0.00% | – |
Q1 2021 | $773,000 | -31.5% | 236,986 | -28.4% | 0.00% | – |
Q4 2020 | $1,128,000 | +154.1% | 330,959 | +204.2% | 0.00% | – |
Q3 2020 | $444,000 | -71.1% | 108,800 | -76.0% | 0.00% | – |
Q2 2020 | $1,536,000 | +353.1% | 454,215 | +212.1% | 0.00% | – |
Q1 2020 | $339,000 | -73.1% | 145,549 | -58.0% | 0.00% | – |
Q4 2019 | $1,260,000 | +43.8% | 346,312 | +228.2% | 0.00% | – |
Q3 2019 | $876,000 | -87.8% | 105,529 | -87.3% | 0.00% | -100.0% |
Q2 2019 | $7,170,000 | +73.2% | 832,712 | +115.0% | 0.00% | +50.0% |
Q1 2019 | $4,140,000 | +96.8% | 387,229 | +61.0% | 0.00% | +100.0% |
Q4 2018 | $2,104,000 | -93.0% | 240,494 | -86.5% | 0.00% | -92.9% |
Q3 2018 | $29,981,000 | +5.6% | 1,784,631 | +31.7% | 0.01% | 0.0% |
Q2 2018 | $28,398,000 | +1192.6% | 1,354,864 | +891.8% | 0.01% | – |
Q1 2018 | $2,197,000 | +60.0% | 136,601 | +88.4% | 0.00% | – |
Q4 2017 | $1,373,000 | -14.7% | 72,500 | -36.6% | 0.00% | -100.0% |
Q3 2017 | $1,610,000 | +88.1% | 114,414 | -0.4% | 0.00% | 0.0% |
Q2 2017 | $856,000 | -64.9% | 114,914 | -69.4% | 0.00% | -50.0% |
Q1 2017 | $2,439,000 | -11.1% | 375,249 | -39.4% | 0.00% | -33.3% |
Q4 2016 | $2,743,000 | +198.5% | 619,082 | +214.9% | 0.00% | +200.0% |
Q3 2016 | $919,000 | +27.6% | 196,614 | +79.5% | 0.00% | 0.0% |
Q2 2016 | $720,000 | +1163.2% | 109,525 | +1052.3% | 0.00% | – |
Q4 2015 | $57,000 | -74.0% | 9,505 | -74.1% | 0.00% | – |
Q3 2015 | $219,000 | -96.6% | 36,718 | -96.6% | 0.00% | -100.0% |
Q1 2015 | $6,494,000 | +908.4% | 1,069,827 | +1051.0% | 0.01% | +500.0% |
Q4 2014 | $644,000 | -76.2% | 92,944 | -72.0% | 0.00% | -66.7% |
Q3 2014 | $2,702,000 | +466.5% | 331,931 | +465.2% | 0.00% | +200.0% |
Q2 2014 | $477,000 | -21.7% | 58,729 | -24.4% | 0.00% | 0.0% |
Q1 2014 | $609,000 | +80.7% | 77,703 | +103.9% | 0.00% | – |
Q4 2013 | $337,000 | +49.1% | 38,116 | +41.6% | 0.00% | – |
Q3 2013 | $226,000 | -8.1% | 26,919 | -18.4% | 0.00% | – |
Q2 2013 | $246,000 | – | 32,976 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Consonance Capital Management LP | 6,963,756 | $145,960,000 | 9.42% |
Avoro Capital Advisors LLC | 3,419,818 | $71,679,000 | 2.76% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 300,000 | $6,285,000 | 2.41% |
Cormorant Asset Management, LP | 1,200,000 | $25,152,000 | 1.86% |
Sio Capital Management, LLC | 143,550 | $3,009,000 | 1.66% |
ASHFORD CAPITAL MANAGEMENT INC | 425,702 | $8,923,000 | 1.18% |
PURA VIDA INVESTMENTS, LLC | 130,700 | $2,739,000 | 1.10% |
Sonora Investment Management, LLC | 298,967 | $6,266,000 | 0.97% |
PURA VIDA INVESTMENTS, LLC | 100,000 | $2,096,000 | 0.84% |
J. Goldman & Co LP | 694,338 | $14,553,000 | 0.75% |